148 related articles for article (PubMed ID: 31191048)
21. Preliminary study on the effect of four-phasic estradiol valerate and dienogest (E2V/DNG) oral contraceptive on the quality of sexual life.
Caruso S; Agnello C; Romano M; Cianci S; Lo Presti L; Malandrino C; Cianci A
J Sex Med; 2011 Oct; 8(10):2841-50. PubMed ID: 21810188
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest.
Zeun S; Lu M; Uddin A; Zeiler B; Morrison D; Blode H
Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):221-32. PubMed ID: 19565420
[TBL] [Abstract][Full Text] [Related]
23. Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature.
Nappi RE; Serrani M; Jensen JT
Int J Womens Health; 2014; 6():711-8. PubMed ID: 25120376
[TBL] [Abstract][Full Text] [Related]
24. Quadriphasic versus monophasic oral contraceptives for contraception.
Van Vliet HA; Raps M; Lopez LM; Helmerhorst FM
Cochrane Database Syst Rev; 2011 Nov; (11):CD009038. PubMed ID: 22071862
[TBL] [Abstract][Full Text] [Related]
25. Discontinuation of modern hormonal contraceptives: an Italian survey.
Fruzzetti F; Perini D; Fornaciari L; Russo M; Bucci F; Gadducci A
Eur J Contracept Reprod Health Care; 2016 Dec; 21(6):449-454. PubMed ID: 27715345
[TBL] [Abstract][Full Text] [Related]
26. Hormone withdrawal-associated symptoms: comparison of oestradiol valerate/dienogest versus ethinylestradiol/norgestimate.
Jensen JT; Parke S; Mellinger U; Serrani M; Mabey RG
Eur J Contracept Reprod Health Care; 2013 Aug; 18(4):274-83. PubMed ID: 23638631
[TBL] [Abstract][Full Text] [Related]
27. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
[TBL] [Abstract][Full Text] [Related]
28. Treatment of heavy menstrual bleeding with the estradiol valerate and dienogest oral contraceptive pill.
Micks EA; Jensen JT
Adv Ther; 2013 Jan; 30(1):1-13. PubMed ID: 23239397
[TBL] [Abstract][Full Text] [Related]
29. Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation.
Rosenberg MJ; Waugh MS; Meehan TE
Contraception; 1995 May; 51(5):283-8. PubMed ID: 7628201
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and bleeding profile of a combined oral contraceptive containing oestradiol valerate/dienogest: a pooled analysis of three studies conducted in North America and Europe.
Nelson A; Parke S; Makalova D; Serrani M; Palacios S; Mellinger U
Eur J Contracept Reprod Health Care; 2013 Aug; 18(4):264-73. PubMed ID: 23651474
[TBL] [Abstract][Full Text] [Related]
31. Effects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: results from the multicentre, randomised, double-blind, active-controlled HARMONY II study.
Macìas G; Merki-Feld GS; Parke S; Mellinger U; Serrani M
J Obstet Gynaecol; 2013 Aug; 33(6):591-6. PubMed ID: 23919857
[TBL] [Abstract][Full Text] [Related]
32. Oral contraceptive containing natural estradiol for premenopausal women.
Hirvonen E; Allonen H; Anttila M; Kulmala Y; Ranta T; Rautiainen H; Sipilä P; Ylöstalo P
Maturitas; 1995 Jan; 21(1):27-32. PubMed ID: 7731379
[TBL] [Abstract][Full Text] [Related]
33. Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies.
Endrikat J; Parke S; Trummer D; Schmidt W; Duijkers I; Klipping C
Contraception; 2008 Sep; 78(3):218-25. PubMed ID: 18692612
[TBL] [Abstract][Full Text] [Related]
34. Review of clinical experience with estradiol in combined oral contraceptives.
Fruzzetti F; Bitzer J
Contraception; 2010 Jan; 81(1):8-15. PubMed ID: 20004267
[TBL] [Abstract][Full Text] [Related]
35. What role for Qlaira in contraception?
Drug Ther Bull; 2010 Sep; 48(9):102-5. PubMed ID: 20810709
[TBL] [Abstract][Full Text] [Related]
36. Clinical comparison of two low-dose oral contraceptives, Minulet and Mercilon, in women over 30 years of age.
Kirkman RJ; Pedersen JH; Fioretti P; Roberts HE
Contraception; 1994 Jan; 49(1):33-46. PubMed ID: 8137624
[TBL] [Abstract][Full Text] [Related]
37. Comparative study on the efficacy, acceptability, and side effects of a contraceptive pill administered by the oral and the vaginal route: an international multicenter clinical trial.
Coutinho EM; Mascarenhas I; de Acosta OM; Flores JG; Gu ZP; Ladipo OA; Adekunle AO; Otolorin EO; Shaaban MM; Abul Oyoon M
Clin Pharmacol Ther; 1993 Nov; 54(5):540-5. PubMed ID: 8222497
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the effects of rifampicin, ketoconazole and erythromycin on the steady-state pharmacokinetics of the components of a novel oral contraceptive containing estradiol valerate and dienogest in healthy postmenopausal women.
Blode H; Zeun S; Parke S; Zimmermann T; Rohde B; Mellinger U; Kunz M
Contraception; 2012 Oct; 86(4):337-44. PubMed ID: 22445438
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and Safety of Estradiol Valerate/Dienogest for the Management of Heavy Menstrual Bleeding: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase III Clinical Trial.
Yu Q; Zhou Y; Suturina L; Jaisamrarn U; Lu D; Parke S
J Womens Health (Larchmt); 2018 Oct; 27(10):1225-1232. PubMed ID: 29957101
[TBL] [Abstract][Full Text] [Related]
40. Impact of estradiol valerate/dienogest on work productivity and activities of daily living in women with heavy menstrual bleeding.
Wasiak R; Filonenko A; Vanness DJ; Law A; Jeddi M; Wittrup-Jensen KU; Stull DE; Siak S; Jensen JT
J Womens Health (Larchmt); 2013 Apr; 22(4):378-84. PubMed ID: 23586801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
